Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer by A. Yu. Goryainova, A. I. Stukan, A. I. Trofimenko, A. A. Meshcheryakov

Connect to this object online.

100 years of Moschcowitz disease and thrombotic microangiopathy research: a look into the past and prospects by A. Yu. Shatilina, A. B. Hajiyeva, L. M. Valikhanova, A. A. Meshcheryakov, N. R. Gashimova, K. N. Grigoreva, A. V. Vorobev

Connect to this object online.

High rate of mutations in the BRCA1, BRCA2, CHEK2, NBN, and BLM genes in Russian ovarian cancer patients by Ye. I. Bateneva, M. G. Filippova, A. S. Tyulyandina, A. A. Meshcheryakov, K. I. Zhordania, A. N. Gritsai, V. V. Kadochnikova, D. D. Abramov, A. A. Ragimov, D. Yu. Trofimov, L. N. Lyubchenko

Connect to this object online.

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II-III triple-negative breast cancer by O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov

Connect to this object online.